NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Anavex Life Sciences Corp. 

14 Rue Kleberg

Geneva    CH-1201  Switzerland
Phone: 416-489-0092 or 866-505-2895 Fax: n/a


SEARCH JOBS










 Company News
Anavex Life Sciences Corp. (AVXL.OB) Completes Scale-up Manufacturing of ANAVEX 2-73 for Phase I Alzheimer's Disease Clinical Trials 9/21/2009 10:35:17 AM    More...
Anavex Life Sciences Corp. (AVXL.OB) Reports Sigma Receptor Review Published in Leading Journal 8/27/2009 9:05:16 AM    More...
Anavex Life Sciences Corp. (AVXL.OB) Announces New CEO, Dr. Herve de Kergrohen 6/16/2009 8:02:11 AM    More...
Anavex Life Sciences Corp. (AVXL.OB) Appoints Leading Alzheimer's Disease Expert Dr. Mark Smith To Scientific Advisory Board 2/10/2009 2:51:23 PM    More...
Anavex Life Sciences Corp. (AVXL.OB) Scales Up Synthesis of Anavex 2-73 for Phase 1 Alzheimer's Disease Study 2/2/2009 1:22:45 PM    More...
Anavex Life Sciences Corp. (AVXL.OB) Release: Ground-Breaking Anti-Amnesic And Neuroprotective Effects Of Alzheimer’s Compound Anavex 1-41 Published In Journal Of Neuropsychopharmacology 12/17/2008 1:57:32 PM    More...
Anavex Life Sciences Corp. (AVXL.OB) Presents Potent Neuroprotective Effects Of Anavex 1-41 At Neuroscience 2008 12/4/2008 2:10:51 PM    More...
Anavex Life Sciences Corp. (AVXL.OB) Completes Successful Preclinical Studies on Lead Alzheimer's Drug Candidate 9/2/2008 11:36:52 AM    More...
Anavex Life Sciences Corp. (AVXL.OB) Presents Neuroprotective Effects of ANAVEX 1-41 7/30/2008 2:37:45 PM    More...
Anavex Life Sciences Corp. (AVXL.OB) will Present New Findings at the International Conference On Alzheimer’s Disease 2008 (July 26-31, 2008, Chicago, Usa) 6/25/2008 12:22:29 PM    More...
123